货号 | 21803-10mg |
描述 | MK-0812 is a potent C-C chemokine receptor type 2 (CCR2) antagonist (IC50 = 5 nM for human CCR2).1 In a mouse model of antibody-induced arthritis, MK-0812 did not affect disease severity.2 Clinical trials for the use of MK-0812 for rheumatoid arthritis and multiple sclerosis were terminated early due to a lack of efficacy.3,4 |
供应商 | Cayman |
应用文献 | |
1.Abagyan, R.,Christopoulos, A.,de Esch, I.J.P., et al. Chemokines and their receptors in drug discovery. Chemokines. Chemokines and their receptors in drug discovery 1-248 (2015). 2.Min, S.-H.,Wang, Y.,Gonsiorek, W., et al. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis. Biochem. Biophys. Res. Commun. 391(1), 1080-1086 (2010). 3.Zhao, Q. Dual targeting of CCR2 and CCR5: Therapeutic potential for immunologic and cardiovascular diseases. J. Leukoc. Biol. 88(1), 41-55 (2010). 4.Horuk, R. Chemokine receptor antagonists: Overcoming developmental hurdles. Nat. Rev. Drug Discov. 8(1), 23-33 (2009). | |
运输条件 | Room temperature in continental US; may vary elsewhere |
存放说明 | -20 |
纯度 | ≥98% |
计算分子量 | 469.5 |
分子式 | C24H34F3N3O3 |
CAS号 | 624733-88-6 |
稳定性 | ≥ 2 years |
本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。 |